[Effect of subchronic administration of tolcapone on release of striatum dopamine and its metabolites induced by L-DOPA and carbidopa]

Biull Eksp Biol Med. 1998 Feb;125(2):168-71.
[Article in Russian]
No abstract available

MeSH terms

  • 3,4-Dihydroxyphenylacetic Acid / pharmacology
  • Animals
  • Antiparkinson Agents / administration & dosage
  • Antiparkinson Agents / pharmacology*
  • Benzophenones / administration & dosage
  • Benzophenones / pharmacology*
  • Carbidopa / pharmacology
  • Catechol O-Methyltransferase Inhibitors*
  • Corpus Striatum / drug effects*
  • Corpus Striatum / metabolism
  • Dopamine / metabolism*
  • Dopamine Agents / pharmacology
  • Drug Synergism
  • Enzyme Inhibitors / pharmacology*
  • Homovanillic Acid / metabolism
  • Levodopa / pharmacology
  • Male
  • Nitrophenols
  • Rats
  • Rats, Wistar
  • Tolcapone

Substances

  • Antiparkinson Agents
  • Benzophenones
  • Catechol O-Methyltransferase Inhibitors
  • Dopamine Agents
  • Enzyme Inhibitors
  • Nitrophenols
  • 3,4-Dihydroxyphenylacetic Acid
  • Levodopa
  • Tolcapone
  • Carbidopa
  • Dopamine
  • Homovanillic Acid